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Background: Laparoscopic peritoneal lavage is an alternative to sigmoid resection in selected patients
presenting with purulent peritonitis from perforated diverticulitis. Although recent trials have lacked
superiority for lavage in terms of morbidity, mortality was not compromised, and beneficial secondary
outcomes were shown. These included shorter duration of surgery, less stoma formation and less surgical
reintervention (including stoma reversal) for laparoscopic lavage versus sigmoid resection respectively.
The cost analysis of laparoscopic lavage for perforated diverticulitis in the Ladies RCT was assessed in
the present study.
Methods: This study involved an economic evaluation of the randomized LOLA (LaparOscopic LAvage)
arm of the Ladies trial (comparing laparoscopic lavage with sigmoid resection in patients with purulent
peritonitis due to perforated diverticulitis). The actual resource use per individual patient was docu-
mented prospectively and analysed (according to intention-to-treat) for up to 1 year after randomization.
Results: Eighty-eight patients were randomized to either laparoscopic lavage (46) or sigmoid resection
(42). The total medical costs for lavage were lower (mean difference €−3512, 95 per cent bias-corrected
and accelerated c.i.−16020 to 8149). Surgical reintervention increased costs in the lavage group, whereas
stoma reversal increased costs in the sigmoid resection group. Differences in favour of laparoscopy were
robust when costs were varied by ±20 per cent in a sensitivity analysis (mean cost difference €− 2509 to
−4438).
Conclusion: Laparoscopic lavage for perforated diverticulitis is more cost-effective than sigmoid
resection.
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Introduction
Diverticular disease is one of the most costly gastro-
intestinal disorders, with an estimated incidence of 1⋅85 per
100 000 population per year for purulent peritonitis from
perforated diverticulitis1–3. Case series have shown laparo-
scopic peritoneal lavage as a promising alternative for sig-
moid resection in patients with purulent peritonitis due to
perforated diverticulitis. This non-resectional strategy was
first described in 1996 and developed further in 20084,5.
A systematic review of case series showed a mortality rate
of less than 5 per cent, and a colostomy was avoided in
the majority of patients6. However, prospective studies7–9
have not been able to reproduce all advantages in a ran-
domized setting. In these trials, laparoscopic lavage did not
result in a reduction of morbidity, although mortality was
better or similar. The shorter duration of surgery, reduc-
tion of stoma formation and lower associated costs may
benefit patients managed with laparoscopic lavage alone.
An economic evaluation of laparoscopic lavage compared
with sigmoid resection based on patients in the LOLA
(LaparOscopic LAvage) arm of the Ladies trial was under-
taken and the findings are presented here.
Methods
This economic evaluation was conducted as part of the
Ladies trial, a randomized open-label multicentre trial
comparing laparoscopic lavage with sigmoid resection for
perforated diverticulitis. Details of the design, conduct and
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clinical findings have been reported elsewhere7,10. In brief,
patients with suspected perforated diverticulitis, clinical
signs of general peritonitis and radiological findings of
diffuse free intraperitoneal air or fluid were eligible for
inclusion. Patients with Hinchey IV peritonitis or overt
perforation could be included only in the DIVA (perfo-
rated DIVerticulitis: sigmoid resection with or without
Anastomosis) arm. The DIVA arm is ongoing, whereas
this laparoscopic lavage (LOLA) arm was terminated early
at the planned interim analysis. At that time, 88 patients
with purulent peritonitis were included in the LOLA arm.
The study protocol was approved by the ethical review
board, and written informed consent was obtained
from all patients before randomization. This study was
investigator-initiated and designed in accordance with
the declaration of Helsinki and good clinical practice
guidelines. The study is registered with ClinicalTrials.gov
(NCT 01317485), and the original study protocol includes
the economic evaluation presented here10.
Economic evaluation
The planned economic evaluation in the protocol esti-
mated the costs and cost-effectiveness of laparoscopic
lavage versus sigmoid resection for up to 12months after
randomization from a societal perspective in the Nether-
lands. Health outcomes in the cost-effectiveness analy-
sis were major morbidity and mortality up to 12months
and quality-adjusted life-years (QALYs) at 12months. As
no difference was shown for either primary clinical out-
come or QALYs between groups in the primary paper7, a
cost-effectiveness or cost-utility analysis could not provide
any useful information and is not presented in this paper;
however, details can be found in Appendix S1 (supporting
information).
A model-based analysis was planned to extrapolate the
results of lavage and estimate the cost for both treatment
options in the long term. Dutch government 2012 tables
were used to estimate the remaining life expectancy at the
time of surgery, and to calculate the costs for the remain-
ing years of life after the end of follow-up at 12months11.
The costs were weighted by the probabilities of occur-
rence in a decision-tree model. The probability of stoma
reversal beyond 12months was estimated at 30 per cent
for those alive with a stoma, with a success rate of 93 per
cent and a mortality rate of 1 per cent12. The rate of read-
mission for recurrent diverticulitis beyond 12months was
estimated at 35 per cent of patients in whom the sigmoid
remained in situ, with a subsequent risk of elective sigmoid
resection of 15 per cent13,14. The risk of abdominal wall
hernia requiring surgical repair is estimated at 21 per 1000
patient-years for laparoscopic procedures and 39 per 1000
patient-years for open colonic surgery15. The robustness of
these estimates was tested by varying the risks in one-way
sensitivity analyses.
A post hoc sensitivity analysis of indirect non-medical
costs, owing to absence from paid work, was performed
because only a minority of the included patients had paid
employment at the time of randomization. Thus, the group
of patients aged less than 60 years was used according to
the stratification during randomization as a subgroup for
this analysis. Although the official age for retirement in the
Netherlands was 65 years at the time of randomization, it
was then still common to retire at age 60 years, and only six
of 53 patients aged over 60 years had a paid job.
Resource utilization
Healthcare utilization and use of other resources were
documented prospectively for individual patients accord-
ing to the predefined protocol10. Resource use was docu-
mented within the study clinical record forms or retrieved
from the regular questionnaire responses. There was no
additional study-related resource use or costs. Data for
resource utilization included direct medical costs: the pri-
mary hospital admission (such as ward and ICU stay) and
primary surgery; all additional procedures including surgi-
cal reinterventions and percutaneous interventions; addi-
tional diagnostic imaging (for example diagnostic plain
X-rays and CT); readmissions; stoma care, stoma rever-
sal surgery and related hospital admission; outpatient con-
sultation visits (with surgeon, gastroenterologist, general
practitioner, physiotherapist or company physician); and
formal home care (assistance with household tasks, per-
sonal care or nursing). Direct non-medical costs included
out-of-pocket costs for travel expenses and informal home
care. Direct medical and non-medical resource use was
documented in patient-reported questionnaires at 1, 3, 6,
9 and 12months.
Indirect non-medical costs as a result of absence from
paid work or lowered productivity while at work were
determined using the Health and Labour Questionnaire16
at 1, 3, 6, 9 and 12months. The friction costs method
was used to estimate the duration of lost productivity,
with age-adjusted average daily wages based on the Dutch
guideline17. The EuroQol – 5D (EQ-5D™; EuroQol
Group, Rotterdam, The Netherlands) questionnaire, val-
ued to the Dutch tariff, was converted to QALYs using the
area under the curve method. As QALYs were measured at
2weeks, 4weeks, 3months and 6months after surgery, the
6-month data were extrapolated to 12months.
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Table 1 Unit costs for major resources used
Costs (€) Unit
Laparoscopic lavage 2056⋅63 Procedure
Hartmann’s procedure* 2847⋅84 Procedure
Primary anastomosis 3437⋅23 Procedure
Surgical ward 485⋅43 Day
ICU 2318⋅80 Day
Ileostomy reversal 2464⋅75 Procedure
Colostomy reversal 3694⋅05 Procedure
Percutaneous drainage 161⋅85 Procedure
Acute relaparotomy 3226⋅77 Procedure
Elective sigmoid resection 3960⋅50 Procedure
Incisional hernia repair 1211⋅15 Procedure
Mean calculated costs per patient, based on individual patient data,
indexed for 2012. *Non-restorative sigmoid resection.
Unit costs
Estimates of unit costs were derived from several dif-
ferent sources: the Dutch guideline on unit costing in
healthcare17; the Hospital Costs ledger 2012 from the
Academic Medical Centre (AMC), Amsterdam, based on
top-down cost calculations; and separate bottom-up cost
calculations within the AMC for the costs of the index sur-
gical procedures. These bottom-up calculations were per-
formed for laparoscopic lavage and laparoscopic and open
sigmoid resection with and without primary anastomosis.
Procedure costs included costs for all reusable instruments
and disposables, and costs for personnel and overhead per
time unit. For the sigmoid resection group, mean costs
for each randomized patient were calculated based on the
actual ratio of these different possible procedures, such as
open and laparoscopic surgery and colostomy, ileostomy, or
none. All costs were expressed in euros and inflated when
necessary to 2012, using the price index rate for the Dutch
healthcare sector (Table 1 for summary and Table S1 (sup-
porting information) for full details). If different unit costs
were available for academic and non-academic hospitals,
each was applied to the respective patients.
Power calculation
The LOLA arm of the Ladies trial was powered on the
primary clinical outcome with a sample size of 264. The
mean(s.d.) costs for the sigmoid resection group were esti-
mated at €28 000(21 000) in the first year18. At the time of
study design, it was assumed there would be a low rate of
reintervention, with the lack of stoma reversal and asso-
ciated costs in the lavage group. Therefore, the cost of
lavage was estimated at approximately €18 000 in the first
year. With the present sample size of 88 patients, a power
of 0⋅73 could be achieved. A minimum cost reduction of
€9000 would be required to achieve a power above 0⋅80.
Table 2 Baseline characteristics and clinical outcomes
Laparoscopic
lavage (n=46)
Sigmoid
resection
(n= 42)
Age (years)* 62⋅3(12⋅7) 64⋅0(12⋅3)
Sex ratio (M : F) 26 : 20 25 : 17
BMI (kg/m2)* 27⋅6(6⋅2) 27⋅0(4⋅4)
Duration of surgery (min)† 60 (48–82) 120 (99–150)
Laparoscopic lavage 45 1
Hartmann’s procedure 1 21
Primary anastomosis 0 20
Remaining life expectancy (years)* 22⋅3(10⋅5) 21⋅7(9⋅5)
Values are *mean(s.d.) and †median (i.q.r.).
Any increase in the standard deviation would reduce the
power further.
Statistical analysis
Resource use per patient was multiplied by unit costs,
and total costs per patient were calculated. Mean resource
use and mean costs per patient for the two groups were
reported. Data are reported as mean(s.d.), median (i.q.r.),
or number with percentage of the group as appropriate. As
most volumes of resource utilization follow a skewed distri-
bution, 95 per cent confidence intervals around the differ-
ences in mean costs were calculated by bias-corrected and
accelerated (BCaCI) bootstrapping. Bootstrapping gener-
ates multiple replications of the statistic of interest by sam-
pling (1000 samples) with replacement from the original
data19.
Robustness of the results for uncertainty in the assump-
tions and estimates was evaluated in sensitivity analyses, by
varying unit costs for pertinent volumes of healthcare uti-
lization and a subgroup analysis based on age.
All analyses were performed for the randomized groups
according to the intention-to-treat principle, with costs
calculated for the procedure actually performed. Analy-
ses were done using SPSS® version 22⋅0 software (IBM,
Armonk, New York, USA) and R version 2⋅13.1 (R Foun-
dation for Statistical Computing, Vienna, Austria).
Results
Between 1 July 2010 and 22 February 2013, a total of
88 patients were randomized and analysed in the LOLA
arm of the Ladies trial; there were 46 patients in the
laparoscopic lavage and 42 in the sigmoid resection group
(20 sigmoid resection with end colostomy and 22 sigmoid
resection with primary anastomosis, of whom 14 had a
diverting ileostomy). All 88 randomized patients were
included in the cost analysis. Baseline characteristics are
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Table 3 Resource utilization and mean costs per patient, indexed for 2012
Laparoscopic lavage (n=46) Sigmoid resection (n=42)
Unit Mean units Mean costs (€) Mean units Mean costs (€) Cost difference (€)
Index admission
Index surgery Procedure 1⋅0 2074 1⋅0 3110
Surgical ward Days 12⋅7 7370 12⋅9 7517
ICU Days 2⋅5 5505 2⋅8 6185
Additional imaging Test 3⋅0 293 2⋅9 213
Subtotal 15 276 17111 −1834 (−13866, 7976)
Readmission and reinterventions
Acute reinterventions Procedure 0⋅7 1170 0⋅2 628
Elective reinterventions Procedure 0⋅3 974 0⋅2 190
Readmission ward Day 7⋅4 4343 5⋅4 2899
Readmission ICU Day 0⋅1 285 0⋅1 156
Subtotal 6786 3873 2912 (−478, 6355)
Stoma-related costs
Stoma care Day 19⋅1 1019 89⋅2 2655
Reversal surgery Procedure 0⋅1 396 0⋅5 1806
Reversal ward admission Day 0⋅7 355 3⋅5 2025
Subtotal 1769 6590 −4821 (−7409, −2560)
Other
Imaging Unit 0⋅8 89 0⋅7 108
Consultations and travel Visit 4⋅6 352 5⋅3 363
Home and informal care Hour 57⋅7 1257 46⋅6 950
Total medical costs 25 393 28905 −3512 (−16020, 8149)
Indirect non-medical costs Hour 54⋅3 1731 141⋅8 4520 −2789 (−2789, 1810)
Total costs (12months) 27 125 33425 −6300 (−18804, 6546)
Values in parentheses are 95 per cent bias-corrected and accelerated confidence intervals. Some smaller cost groups are not shown (transfusion,
consultations in the emergency room, general practitioner and outpatient clinic, travel expenses, separate home and informal care costs), but are included
in subtotal and total costs.
presented in Table 2. For the Health and Labour Question-
naire, used to determine production losses, the response
rate was 55 (64 per cent) of 86 patients alive at 2weeks,
and 49 (63 per cent) of 78 patients alive at 12months.
Some 69 patients (78 per cent) completed at least one of
the questionnaires.
A summary of mean costs per patient per group, includ-
ing mean differences, is shown in Table 3. During the index
admission, a trend for lower costs for lavage was seen (mean
difference (MD) €− 1834, 95 per cent BCaCI −13 866
to 7976), and the costs of stoma care and stoma reversal
were lower by €− 4821 (−7409 to −2560) in the lavage
group. Costs for reintervention in the lavage group showed
a trend for higher costs by €2912 (−478 to 6355). Together,
this resulted in total medical costs for the 12-month study
of €25 393 per patient in the lavage group and €28 905
per patient in the sigmoid resection group (MD €− 3512,
−16 020 to 8149). A small proportion of patients con-
tributed to the majority of the costs. The 10 per cent most
costly patients contributed 33 per cent of the total costs,
caused mostly by their prolonged hospital and ICU stay.
Long-term costs were calculated for the period from
12months after surgery to the end of life, which was
calculated as a mean of 22months additional survival per
patient alive (Table 2). Six patients in each group had a
colostomy beyond 12months, and costs were estimated at
€82 359 and €95 592 per patient with a stoma for their
remaining life, for the lavage and sigmoid resection group
respectively. In addition, the risk of recurrent diverticulitis
(35 per cent for patients without sigmoid resection, 5 per
cent for those who had sigmoid resection) and subsequent
elective sigmoid resection and the risk of hernia surgerywas
taken into account. This resulted in an additional €13 884
for the lavage group and €18 133 for the sigmoid resection
group for patients alive, with total medical costs to the
end of life of €38 070 and €44 448 per patient respectively
(MD €− 6377, 95 per cent BCaCI −26 221 to 12 175). The
estimated medical costs per subgroup, for follow-up from
12months to estimated end-of-life per patient, are shown
in Table S2 (supporting information).
Sensitivity analyses
Sensitivity analysis was used to account for the uncer-
tainty around the calculated costs. Costs are known to vary
between hospitals and countries, and thus major costs var-
ied by ±20 per cent for both groups. For index procedure
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Table 4 Sensitivity analysis of medical costs
Laparoscopic
lavage (€)
Sigmoid
resection (€)
Cost
difference (€)
Base analysis 25 393 28 905 −3512 (−16020, 8149)
Index surgery
−50% 24308 27264 −2956 (−18370, 9191)
+50% 27382 31374 −3992 (−19244, 8153)
Hospital stay (ward,
ICU)
−20% 22998 26286 −3288 (−16020, 7393)
+20% 28262 31871 −3609 (−21010, 10 523)
Stoma-associated
costs
−20% 24991 27501 −2509 (−17572, 9410)
+20% 25699 30137 −4438 (−19645, 8041)
Acute or elective
relaparotomy
−20% 24916 28655 −3739 (−18580, 8246)
+20% 25774 28983 −3209 (−18820, 9109)
Costs for individual cost groups are increased or decreased by the
specified percentage; all other cost groups remained constant. Values in
parentheses are 95 per cent bias-corrected and accelerated confidence
intervals.
costs,±50 per cent was used as these costs in particular tend
to vary between hospitals. The total cost difference of these
sensitivity analyses varied between €− 2509 and −4438 in
favour of laparoscopic lavage, demonstrating consistently
higher costs associated with sigmoid resection (Table 4).
The impact of production losses on overall costs was lim-
ited as, owing to their age, only a minority of the included
patients had paid employment. When calculating produc-
tion losses for the group of patients aged less than 60 years
(lavage, 17; resection, 16), the losses were greater in the
resection group (lavage €2578 versus resection €11 230;
MD €− 8652, 95 per cent BCaCI −17 879 to −1448), con-
tributing to further reduction of the total costs at 1 year in
the lavage group (€24 612 versus €36 239 in the resection
group; MD €− 11 627, −27 573 to 6706).
Discussion
Although laparoscopic lavage was not superior to sigmoid
resection with regard to the primary clinical outcome
(morbidity), beneficial secondary outcomes have been
shown7. These secondary outcomes include shorter dura-
tion of surgery (60 versus 120min), lower rate of stoma
formation (26 versus 81 per cent), and higher number of
patients with no surgical reintervention (including stoma
reversal) (57 versus 36 per cent) for laparoscopic lavage
and sigmoid resection respectively. In three-quarters of
the patients, laparoscopic lavage was successful in con-
trolling the abdominal sepsis, and these patients did not
require acute surgical reintervention. Although these
reinterventions accounted for an increased postoperative
morbidity rate in the lavage group, a similar rate of other
adverse events occurred and median postoperative hospital
stay was shorter (8 days for lavage versus 10 days for sig-
moid resection). The postoperative mortality rate was low
in both groups (2 of 46 patients in the lavage group and 1
of 42 in the sigmoid resection group), such that statistical
comparison was not possible.
From the present clinical data for up to 12months after
surgery, it can only be hypothesized whether or not the
avoidance of acute sigmoid resection is of benefit. By avoid-
ing acute resection, most late colectomy operations could
be performed laparoscopically and with primary anastomo-
sis without loop ileostomy. Thus, quality of life is main-
tained, additional stoma reversal surgery is avoided, and
the risk of abdominal wall hernia is reduced by avoiding
laparotomy20. Formost patients, elective sigmoid resection
has a similar morbidity risk and similar length of hospital
stay compared with end colostomy reversal21,22.
The cost differences per cost group (such as index
surgery, readmissions and reinterventions, stoma-related
costs) are in line with the clinical outcomes reported
previously7. Some factors reduce costs, such as shorter
duration of surgery, whereas others increase costs.
Increased costs were found in the lavage group as a
result of surgical reintervention, whereas stoma care,
productivity losses and stoma reversal surgery were costly
following sigmoid resection. Postoperative hospital ward
stay was the single highest cost, approximately €7500 for
both groups.
As stoma costs contribute strongly to the increased costs
in the resection group, it is important to note that 50 per
cent (21 of 42) of these patients had a Hartmann procedure
and 48 per cent (20 of 42) had a primary anastomosis, as
randomized within the ongoing DIVA part of the trial.
Based on the data from non-included patients, about 65 per
cent of patients would undergo Hartmann’s procedure, 15
per cent primary anastomosis and 20 per cent lavage. With
these proportions, cost would be even more in favour of
lavage owing to the high stoma-associated costs. However,
if the hypothesis of the DIVA arm is true and stoma-free
survival for patients in the primary anastomosis group is
increased with equal or improved morbidity rates, the cost
reduction for lavage might even disappear.
These calculations have been performed for a 12-month
follow-up in the Ladies trial, and were extrapolated to end
of life. Stoma-related costs were the highest for the remain-
ing follow-up, at more than €80 000 per patient with a
colostomy. Therefore, the number of non-reversed stomas
per group is of major influence to the total costs, much
higher than the costs associated with recurrence, elective
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sigmoid resection and hernia surgery. Although a signif-
icant proportion of patients with a Hartmann procedure
never have a reversal, the stoma remains a source of expense
throughout the life of these patients23. As 50 per cent of
patients having lavage in the LOLA arm underwent sig-
moid resection within the first year, the other 50 per cent
remain at risk of recurrence and resection in subsequent
years7. Despite the fact that the present study protocol dic-
tated elective surgery only in symptomatic patients, sev-
eral patients had prophylactic elective surgery as a result
of national guidelines and local practice. If current prac-
tice guidelines were implemented fully, a lower rate of sig-
moid resection should be achievable. In the series byMyers
and colleagues5, none of the initially successfully managed
patients required elective sigmoid resection for recurrent
diverticulitis, and only two of 88 were readmitted owing to
recurrence. Overall, this rate was reported as 38 per cent
in the meta-analysis presented in the supplemental data of
the LOLA publication7, but varied between 0 and 100 per
cent as some authors performed routine resection. When
series reporting 0 or 100 per cent were excluded, a sigmoid
resection rate of 54 per cent was found, but less than half
of the studies reported the length of follow-up and time to
resection.
An important limitation of this study is that all cost and
resource calculations were based on the Dutch healthcare
system, where the fixed reimbursement tariff for diverti-
culitis does not depend on actual procedures performed.
Only a small number of patients were included in the
Belgian and Italian hospitals, such that reliable costs could
not be estimated. To allow international interpretation,
a sensitivity analysis for all important subgroups of costs
was performed by varying the unit costs of each subgroup
by −20/50 to +20/50 per cent. Although none of the
calculated total costs was significantly different between
the two groups, there was a robust reduction in costs for
laparoscopic lavage across all analyses. As the study was
terminated early, at just over 30 per cent of the originally
calculated sample size, the power was insufficient to show a
robust statistically significant result. Although the accrual
rate of 34 per cent might have introduced selection bias,
no differences in baseline were found for included and
non-included patients, so selection bias is not apparent7.
Another important limitation was the lack of quality con-
trol for laparoscopic lavage. When designing the study,
laparoscopic lavage was assumed to be a simple procedure
to be performed by any surgeon on call who was expe-
rienced in laparoscopic appendicectomy or similar proce-
dures. However, this might not have been true as reflected
by the high number of included cancers and missed overt
perforations. Many of the surgeons involved had hardly
any experience in laparoscopic lavage for perforated diver-
ticulitis, and the low number of patients per participating
hospital did not provide sufficient patients for a learning
curve during the trial. Training would have been difficult
with these patient numbers, but quality control with video
would have been possible.
Finally, it must be pointed out that end-of-life cost calcu-
lation is based on assumptions about future events rather
than facts, as such data are currently not available. How-
ever, this estimation was considered to be of such clinical
importance, in addition to the available 12-month data,
that it was used rather than waiting for the long-term (ret-
rospective) data from the trial.
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